Enteral nutrition is the administration of food and other nutrients through a tube (a nasogastric tube, or NG tube) or liquid through a feeding line in the nose. Enteral feeds can be administered with a nasal gastronomy needle, long-feeding pipette, small-bore needle, or orally. The main advantage of enterally-administered nutrition is that it avoids at least some nutrient losses due to diarrhea and vomiting.
Enteral nutrition is a delivery system designed and intended to supplement or replace the requirements of a person unable to receive nutrition orally. The term enteral, meaning administered through the gastrointestinal tract, refers to all methods of feeding that are inserted through the mouth into the stomach or intestine.
Highlighted with 122 tables and 89 figures, this 195-page report “Global Enteral Nutrition Market 2020-2030 by Nutrient, Application, Category, Product Form, End User, Distribution Channel, and Region: Trend Forecast and Growth Opportunity” is based on a comprehensive research of the entire global enteral nutrition market and all its sub-segments through extensively detailed classifications.
Request Research Sample with Latest Industry Insights (195+ Pages Report): https://altusmarketresearch.com/reports/sample/29830
Global enteral nutrition market will reach $19.75 billion by 2030, growing by 8.9% annually over 2020-2030 driven by the increasing incidence of malnutrition, rising number of patients suffering with chronic diseases, and surge in adoption of enteral nutrition over parenteral nutrition due to lower cost and complications of enteral nutrition.
Based on Nutrient, the global market is segmented into the following sub-markets with annual revenue ($ mn) for 2019-2030 included in each section.
• Protein Based Nutrition
o Standard Protein Diet
o High Protein Supplement
o Protein for Diabetic Patients
o Other Protein-based Nutitions
• Carbohydrates Based Nutrition
• Fat Based Nutrition
• Vitamin Based Nutrition
• Other Nutrition Types
Based on Application, the global market is segmented into the following sub-markets with annual revenue ($ mn) for 2019-2030 included in each section.
• Critical Care
• Diabetes
• Neurology
• Oncology
• Other Applications
Based on Category, the global market is segmented into the following sub-markets with annual revenue ($ mn) for 2019-2030 included in each section.
• Enteral Nutrition for Chronic Illness
• Enteral Nutrition with Standard Formula
Based on Product Form, the global market is segmented into the following sub-markets with annual revenue ($ mn) for 2019-2030 included in each section.
• Liquid Enteral Nutrition
• Powder Enteral Nutrition
Based on End User, the global market is segmented into the following sub-markets with annual revenue ($ mn) for 2019-2030 included in each section.
• Pediatric
• Adults
• Geriatric
Based on Distribution Channel, the global market is segmented into the following sub-markets with annual revenue ($ mn) for 2019-2030 included in each section.
• Distribution by Hospitals
• Distribution by Retail Pharmacies
• Distribution by Online Pharmacies
The report also covers current competitive scenario and the predicted trend; and profiles key vendors including market leaders and important emerging players.
Key Players (this may not be a complete list and extra companies can be added upon request):
Abbott Laboratories
B. Braun Melsungen AG
Baxter International, Inc.
Danone S.A.
Fresenius Kabi AG
Global Health Products, Inc.
Hormel Foods Corporation
Meiji Holdings Co., Ltd.
Nestle S.A.
Reckitt Benckiser (Mead Johnson & Company LLC)
Victus, Inc.
Geographically, the following regions together with the listed national/local markets are fully investigated:
• North America (U.S., Canada, and Mexico)
• Europe (Germany, UK, France, Spain, Italy, Russia, Rest of Europe; Rest of Europe is further segmented into Netherlands, Switzerland, Poland, Sweden, Belgium, Austria, Ireland, Norway, Denmark, and Finland)
• APAC (Japan, China, South Korea, Australia, India, and Rest of APAC; Rest of APAC is further segmented into Malaysia, Singapore, Indonesia, Thailand, New Zealand, Vietnam, Taiwan, and Philippines)
• South America (Brazil, Colombia, Argentina, Rest of South America)
• MEA (UAE, Saudi Arabia, South Africa)
For each aforementioned region and country, detailed analysis and data for annual revenue ($ mn) are available for 2019-2030. The breakdown of all regional markets by country and split of key national markets by Nutrient, Application, and End User over the forecast years are also included.
